EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ABCC2 Genetic Variation and Vincristine-Induced Peripheral Neuropathy Risk in Mexican Pediatric Patients with Acute Lymphoblastic Leukemia

María Fernanda Monroy-Baroja iD, Carlos Galaviz-Hernandez, Laura María García-Torres, Elio Aarón Reyes-Espinoza, Luis Felipe Cuellar-Guzman iD, Lourdes Patricia Córdova-Hurtado, Laura Jazel Barragan-Zuñiga iD, Martha Sosa-Macías

International Journal of Molecular Sciences · 08.11.2026 · 27 (21) · 9998

DOI: 10.3390/ijms27219998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.11.2026. Verfasst von María Fernanda Monroy-Baroja und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional Unidad Durango (CIIDIR Durango), Instituto Politécnico Nacional, Dura…. Hauptthemen laut MEDLINE: Vincristine, Peripheral Nervous System Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Polymorphism, Single Nucleotide. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Polytechnic Institute, Secretaría de Investigación y Posgrado (SIP) of Instituto Politécnico Nacional.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vincristine-induced peripheral neuropathy (VIPN) is a common dose-limiting toxicity in pediatric acute lymphoblastic leukemia (ALL), and pharmacogenetic evidence in admixed populations remains limited. We evaluated variants in ABCC1, ABCC2, ABCB1, CYP3A4, CYP3A5, and CEP72 in Mexican pediatric patients with ALL using an ambispective case–control design (n = 43; aged 2–18 years). VIPN was graded using CTCAE v4.0; cases were defined as grade ≥ 2 (n = 11) and controls grade 0–1 (n = 32). Nine single nucleotide variants (SNVs) were genotyped by allele-specific qPCR and analyzed under codominant, dominant, recessive, and log-additive models, including haplotype analyses. VIPN occurred in 25.6% of patients, with 90.9% of cases occurring during induction (p = 0.001). ABCC2 rs11190298 was nominally associated with VIPN under codominant (OR = 0.21; 95% CI: 0.04–0.97), dominant (OR = 0.15; 95% CI: 0.03–0.71), and log-additive (OR = 0.17; 95% CI: 0.04–0.66) models, and ABCC2 haplotypes showed a nominal global association (p = 0.003). These associations did not withstand correction for multiple testing. No significant associations were found for ABCC1, ABCB1, CYP3A4, CYP3A5, or CEP72. Early-onset toxicity may reflect differences in drug exposure or treatment intensity, which pharmacokinetic data could clarify. These hypothesis-generating findings require replication in larger prospective cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VincristinePeripheral Nervous System DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaPolymorphism, Single NucleotideATP-Binding Cassette, Sub-Family C ProteinsHumansMultidrug Resistance-Associated Protein 2ChildChild, PreschoolMaleFemaleAdolescentMexicoCase-Control StudiesHaplotypesGenetic Predisposition to DiseaseGenotypeMicrotubule-Associated Proteins

Stichwörter der Autor:innen

ABCC2Mexican populationacute lymphoblastic leukemiapediatric oncologyperipheral neuropathypharmacogeneticsvincristine

Substanzen

Multidrug Resistance-Associated Protein 2ABCC2 protein, humanVincristineATP-Binding Cassette, Sub-Family C Proteinsmultidrug resistance-associated protein 1CEP72 protein, humanMicrotubule-Associated Proteins

Autor:innen und Institutionen

  • Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional Unidad Durango (CIIDIR Durango), Instituto Politécnico Nacional, Durango 34220, Durango, Mexico.
  • Centro Estatal de Cancerología de Durango (CECAN), Secretaria de Salud del Estado de Durango, Durango 34000, Durango, Mexico.

ORCID-Profile: María Fernanda Monroy-Baroja, Luis Felipe Cuellar-Guzman, Laura Jazel Barragan-Zuñiga

Förderung

  • National Polytechnic Institute
  • Secretaría de Investigación y Posgrado (SIP) of Instituto Politécnico Nacional

Zitieren

APA

Monroy-Baroja, M. F., Galaviz-Hernandez, C., García-Torres, L. M., Reyes-Espinoza, E. A., Cuellar-Guzman, L. F., Córdova-Hurtado, L. P., Barragan-Zuñiga, L. J., & Sosa-Macías, M. (2026). ABCC2 Genetic Variation and Vincristine-Induced Peripheral Neuropathy Risk in Mexican Pediatric Patients with Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences, 27(21), 9998. https://doi.org/10.3390/ijms27219998

Vancouver

Monroy-Baroja MF, Galaviz-Hernandez C, García-Torres LM, Reyes-Espinoza EA, Cuellar-Guzman LF, Córdova-Hurtado LP, et al. ABCC2 Genetic Variation and Vincristine-Induced Peripheral Neuropathy Risk in Mexican Pediatric Patients with Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2026;27(21):9998. doi:10.3390/ijms27219998

BibTeX
@article{MonroyBaroja2026,
  author = {Monroy-Baroja, María Fernanda and Galaviz-Hernandez, Carlos and García-Torres, Laura María and Reyes-Espinoza, Elio Aarón and Cuellar-Guzman, Luis Felipe and Córdova-Hurtado, Lourdes Patricia and Barragan-Zuñiga, Laura Jazel and Sosa-Macías, Martha},
  title = {ABCC2 Genetic Variation and Vincristine-Induced Peripheral Neuropathy Risk in Mexican Pediatric Patients with Acute Lymphoblastic Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9998},
  doi = {10.3390/ijms27219998}
}
Kostenlos starten →